| 2023 | 2022 | ||
| Note | £m | £m | |
| Continuing operations | |||
Revenue | 2,3 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Indirect production and engineering expenses | ( | ( | |
Sales and marketing expenses | ( | ( | |
Administrative expenses | ( | ( | |
Operating profit | 2,4 | ||
Fair value through profit and loss movements on debt investments | 27 | ( | |
Share of post-tax results of associates | 2 | ( | |
(Loss)/profit on disposal of businesses | 24 | ( | |
Financial income | 6 | ||
Finance costs | 6 | ( | ( |
Profit before tax | |||
Taxation charge | 7 | ( | ( |
Profit for the year from continuing operations | |||
Profit for the year from discontinued operations | 24 | ||
| Profit for the year from continuing and discontinued operations | |||
attributable to owners of the Company | |||
| Earnings per share | |||
| From continuing operations | |||
Basic | 9 | ||
Diluted | 9 | ||
| From continuing and discontinued operations | |||
Basic | 9 | ||
Diluted | 9 | ||
| Dividends – amounts arising in respect of the year | |||
| Interim dividend paid and final dividend proposed/paid for the year | |||
(per share) | 8 | ||
Dividends paid during the year (per share) | 8 |
| 2023 | 2022 | ||
| Note | £m | £m | |
Profit for the year attributable to owners of the Company | |||
| Other comprehensive (loss)/income: | |||
| Items that will not be reclassified to the Consolidated Income | |||
| Statement: | |||
Re-measurement of net defined benefit obligation | 19 | ( | |
| Fair value (loss)/gain and foreign exchange movements on translation | |||
of investment in equity instruments designated as at fair value through other comprehensive income | 12 | ( | |
Tax credit/(charge) on items above | 7 | ( | |
( | |||
Items that are or may be reclassified subsequently to the Consolidated Income Statement: | |||
| Net gain on effective portion of changes in fair value of forward | |||
exchange contracts on cash flow hedges | |||
Foreign exchange movements on translation of overseas operations | ( | ||
Currency translation differences transferred to profit on disposal of business | 24 | ( | |
Tax charge on items above | 7 | ( | |
( | |||
Total other comprehensive (loss)/income | ( | ||
Total comprehensive income for the year attributable to owners of the Company |
| Capital | |||||||||
| Share | Share | Retained | Translation | Hedging | Merger | redemption | Total | ||
| capital | premium | earnings | reserve | reserve | reserve | reserve | equity | ||
| Note | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2023 | ( | ||||||||
Profit for the year | |||||||||
Other comprehensive (loss)/income | ( | ( | ( | ||||||
Total comprehensive income/(loss) for the year | ( | ||||||||
| Transactions with owners recorded directly in equity: | |||||||||
Equity dividends paid by the Company | 8 | ( | ( | ||||||
Own shares acquired for share buyback programme | 21 | ( | ( | ( | |||||
Share-based payments, net of tax | 22 | ||||||||
Proceeds from exercise of equity-settled options | |||||||||
At 31 December 2023 | |||||||||
| For the year ended 31 December 2022 | Capital | ||||||||
| Share | Share | Retained | Translation | Hedging | Merger | redemption | Total | ||
| capital | premium | earnings | reserve | reserve | reserve | reserve | equity | ||
| Note | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2022 | ( | ||||||||
Profit for the year | |||||||||
Other comprehensive income | |||||||||
Total comprehensive income for the year | |||||||||
| Transactions with owners recorded directly in equity: | |||||||||
Equity dividends paid by the Company | 8 | ( | ( | ||||||
Own shares acquired for share buyback programme | 21 | ( | ( | ( | |||||
Share-based payments, net of tax | 22 | ||||||||
Proceeds from exercise of equity-settled options | |||||||||
At 31 December 2022 | ( |
| 2023 | 2022 | ||
| Note | £m | £m | |
| ASSETS | |||
| Non-current assets | |||
Goodwill | 10 | ||
Other intangible assets | 10 | ||
Property, plant and equipment | 11 | ||
Right-of-use assets | 11 | ||
Investments in equity instruments | 12 | ||
Investment in debt instruments | 27 | ||
Investment in associates | 12 | ||
Derivative financial instruments | 27 | ||
Other receivables | 14 | ||
Deferred tax assets | 20 | ||
Retirement benefit assets | 19 | ||
| Current assets | |||
Inventories | 13 | ||
Current tax assets | |||
Trade and other receivables | 14 | ||
Derivative financial instruments | 27 | ||
Cash and cash equivalents | 15 | ||
Assets held for sale | 24 | ||
Total assets | |||
| LIABILITIES | |||
| Current liabilities | |||
Borrowings | 16 | ( | |
Derivative financial instruments | 27 | ( | ( |
Trade and other payables | 17 | ( | ( |
Lease liabilities | ( | ( | |
Current tax liabilities | ( | ( | |
Provisions | 18 | ( | ( |
Liabilities held for sale | 24 | ( | |
( | ( | ||
Net current assets |
| 2023 | 2022 | ||
| Note | £m | £m | |
| Non-current liabilities | |||
Other payables | 17 | ( | ( |
Derivative financial instruments | 27 | ( | ( |
Lease liabilities | ( | ( | |
Provisions | 18 | ( | ( |
Retirement benefit obligations | 19 | ( | ( |
Deferred tax liabilities | 20 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | |||
| EQUITY | |||
Share capital | 21 | ||
Share premium | |||
Retained earnings | |||
Translation reserve | 21 | ||
Hedging reserve | 21 | ( | |
Merger reserve | 21 | ||
Capital redemption reserve | 21 | ||
Total equity attributable to owners of the Company |
| 2023 | 2022 | ||
| Note | £m | £m | |
Cash generated from operations | 25 | ||
Net income taxes paid | ( | ( | |
Net cash inflow from operating activities | |||
| Cash flows from investing activities | |||
Purchase of property, plant and equipment and intangible assets | ( | ( | |
Proceeds from disposal of property, plant and equipment and software | |||
Acquisition of businesses, net of cash acquired | 23 | ( | ( |
Purchase of investment in associates | 12 | ( | ( |
| Proceeds from disposal of businesses, net of tax paid of £5.9m | |||
(2022: £27.9m) | 24 | ||
Interest received | |||
Net cash (used in)/inflow from investing activities | ( | ||
| Cash flows used in financing activities | |||
Interest paid on borrowings | ( | ( | |
Interest paid on lease liabilities | 16 | ( | ( |
Dividends paid | 8 | ( | ( |
Share buyback purchase of shares | 21 | ( | ( |
Net proceeds from exercise of share options | |||
Payments on principal portion of lease liabilities | 16 | ( | ( |
Proceeds from borrowings | 16 | ||
Repayment of borrowings | 16 | ( | ( |
Net cash outflow used in financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of year | |||
Effect of foreign exchange rate changes | ( | ||
Cash and cash equivalents at end of year | 15 |
Amendments to IFRS 16 | Lease liability in a sale and leaseback |
Amendments to IAS 7 and IFRS 17 | Supplier finance arrangements |
Amendment to IAS 1 | Non-current liabilities with covenants |
Amendments to IAS 1 | Classification of liabilities as current or non-current |
Amendments to IAS 1 | Classification of liabilities as current or non-current – |
| Deferral of effective date | |
Amendments to IAS 21 | Lack of exchangeability |
| IFRS S1 General Requirements for Disclosure of | General requirements for disclosure of |
| Sustainability-related Financial Information | Sustainability-related Financial Information |
| IFRS S2 – Climate-related Disclosures | Climate-related disclosures |
| Carrying amount of | Carrying amount of | |||
| segment assets | segment liabilities | |||
| 2023 | 2022 | 2023 | 2022 | |
| £m | £m | £m | £m | |
Spectris Scientific | 655.0 | 673.8 | (217.6) | (237.7) |
Spectris Dynamics | 746.8 | 766.1 | (210.4) | (193.5) |
Other | 188.3 | 202.7 | (32.5) | (31.9) |
Group-related | 0.4 | 2.6 | (8.9) | (6.7) |
Total segment assets and liabilities | 1,590.5 | 1,645.2 | (469.4) | (469.8) |
Cash and borrowings | 138.5 | 228.1 | – | (0.1) |
Derivative financial instruments | 6.2 | 1.7 | (0.2) | (2.5) |
| Assets and liabilities held for sale that are not allocable | ||||
to a segment | 0.3 | – | (6.7) | – |
Investment in debt instruments | 21.7 | 18.9 | – | – |
Investment in equity instruments | 24.3 | 29.3 | – | – |
Retirement benefit assets and liabilities | 2.4 | – | (11.6) | (8.9) |
Taxation | 33.8 | 24.8 | (13.9) | (29.8) |
Consolidated total assets and liabilities | 1,817.7 | 1,948.0 | (501.8) | (511.1) |
| Depreciation, | ||||
| amortisation and | ||||
| Additions to non-current | impairment from | |||
| assets from continuing | continuing and | |||
| and non-continuing | non-continuing | |||
| operations | operations | |||
| 2023 | 2022 | 2023 | 2022 | |
| £m | £m | £m | £m | |
Spectris Scientific | 45.7 | 68.9 | 18.5 | 23.9 |
Spectris Dynamics | 45.7 | 85.7 | 30.8 | 27.9 |
Omega | – | 0.7 | – | – |
Others | 5.0 | 18.0 | 7.9 | 6.9 |
Group-related | – | 0.6 | 0.5 | 0.6 |
Consolidated total | 96.4 | 173.9 | 57.7 | 59.3 |
| Spectris | Spectris | Group | 2023 | ||
| Information about continuing reportable | Scientific | Dynamics | Other | costs | Total |
| segments | £m | £m | £m | £m | £m |
Segment revenues | 704.4 | 542.8 | 202.2 | – | 1,449.4 |
Inter-segment revenue | (0.2) | – | – | – | (0.2) |
External revenue | 704.2 | 542.8 | 202.2 | – | 1,449.2 |
Operating profit | 124.4 | 56.2 | 33.2 | (25.2) | 188.6 |
Share of post-tax results of associates | (0.4) | 0.3 | – | – | (0.1) |
| Fair value through profit and loss | |||||
| movements on debt investments | 2.8 | ||||
| Loss on disposal of businesses | (12.6) | ||||
| Financial income | 11.0 | ||||
Finance costs 1 | (4.1) | ||||
| Profit before tax | 185.6 | ||||
| Taxation charge | (40.2) | ||||
| Profit after tax from continuing operations | 145.4 |
| Spectris | Spectris | Group | 2022 | ||
| Information about continuing reportable | Scientific | Dynamics | Other | costs | Total |
| segments | £m | £m | £m | £m | £m |
Segment revenues | 658.0 | 492.4 | 177.4 | – | 1,327.8 |
Inter-segment revenue | (0.2) | (0.2) | – | – | (0.4) |
External revenue | 657.8 | 492.2 | 177.4 | – | 1,327.4 |
Operating profit | 118.3 | 46.5 | 26.2 | (18.4) | 172.6 |
| Fair value through profit and loss | |||||
| movements on debt investments | (4.1) | ||||
| Profit on disposal of businesses | 0.3 | ||||
| Financial income | 1.9 | ||||
Finance costs 1 | (19.2) | ||||
| Profit before tax | 151.5 | ||||
| Taxation charge | (36.7) | ||||
| Profit after tax from continuing operations | 114.8 |
| Non-current assets | ||
| 2023 | 2022 | |
| £m | £m | |
UK | 218.8 | 239.3 |
Germany | 70.5 | 86.8 |
France | 7.1 | 7.0 |
| Rest of Europe | 301.2 | 283.4 |
USA | 355.1 | 406.4 |
Rest of North America | 13.2 | 16.0 |
Japan | 4.7 | 5.3 |
China | 9.7 | 9.7 |
South Korea | 0.9 | 1.2 |
Rest of Asia | 8.3 | 8.6 |
Rest of the world | 2.9 | 2.6 |
992.4 | 1,066.3 | |
| Deferred tax assets | 26.6 | 16.2 |
Total non-current assets | 1,019.0 | 1,082.5 |
| Spectris | Spectris | 2023 | ||
| Scientific | Dynamics | Other | Total | |
| £m | £m | £m | £m | |
UK | 27.8 | 21.8 | 6.5 | 56.1 |
Germany | 31.6 | 103.7 | 6.3 | 141.6 |
France | 20.5 | 27.0 | 3.6 | 51.1 |
Rest of Europe | 96.0 | 86.8 | 14.5 | 197. 3 |
USA | 133.6 | 145.7 | 98.2 | 377. 5 |
Rest of North America | 21.7 | 7.6 | 7.8 | 37.1 |
Japan | 41.3 | 30.1 | 6.9 | 78.3 |
China | 149.5 | 73.9 | 26.4 | 249.8 |
South Korea | 36.6 | 11.2 | 4.7 | 52.5 |
Rest of Asia | 98.7 | 22.8 | 21.2 | 142.7 |
Rest of the world | 46.9 | 12.2 | 6.1 | 65.2 |
704.2 | 542.8 | 202.2 | 1,449.2 |
| Spectris | Spectris | 2022 | ||
| Scientific | Dynamics | Other | Total | |
| £m | £m | £m | £m | |
UK | 27.8 | 18.5 | 4.9 | 51.2 |
Germany | 31.5 | 85.4 | 6.5 | 123.4 |
France | 18.2 | 22.7 | 3.9 | 44.8 |
Rest of Europe | 87.8 | 72.6 | 12.0 | 172.4 |
USA | 137.1 | 133.1 | 89.7 | 359.9 |
Rest of North America | 16.6 | 6.7 | 6.7 | 30.0 |
Japan | 36.6 | 29.9 | 3.0 | 69.5 |
China | 132.4 | 74.8 | 26.4 | 233.6 |
South Korea | 42.5 | 10.6 | 5.3 | 58.4 |
Rest of Asia | 85.0 | 25.8 | 14.7 | 125.5 |
Rest of the world | 42.3 | 12.1 | 4.3 | 58.7 |
657.8 | 492.2 | 177.4 | 1,327.4 |
| 2023 | 2022 | |
| Timing of revenue recognition from continuing operations | £m | £m |
| At a point in time: | ||
Spectris Scientific | 642.4 | 577.6 |
Spectris Dynamics | 483.4 | 432.1 |
Others | 202.2 | 177.4 |
1,328.0 | 1,187.1 | |
| Over time: | ||
Spectris Scientific | 61.8 | 80.2 |
Spectris Dynamics | 59.4 | 60.1 |
121.2 | 140.3 | |
Revenue from continuing operations | 1,449.2 | 1,327.4 |
| 2023 | 2022 | ||
| Note | £m | £m | |
Net foreign exchange losses/(gains) included in operating profit | 5.8 | (0.3) | |
Research and development expense | 108.4 | 102.9 | |
Amortisation and other non-cash adjustments made to intangible assets | 10 | 24.9 | 25.1 |
Depreciation of owned property, plant and equipment | 11 | 19.4 | 20.0 |
Depreciation and impairment of right-of-use assets | 11 | 13.4 | 14.0 |
Income from sub-leasing right-of-use assets | (0.5) | (0.3) | |
Expenses relating to short-term and low-value leases | 0.1 | 0.1 | |
Donations to the Spectris Foundation | 1.1 | 0.1 | |
Cost of inventories recognised as expense | 361.2 | 351.9 | |
| Profit on disposal and re-measurements of property, plant and equipment | |||
and associated lease liabilities | (0.5) | (1.5) |
| 2023 | 2022 | |
| Auditor’s remuneration | £m | £m |
Fees payable to the Company’s auditor for audit of the Company’s annual accounts | 0.8 | 0.7 |
Fees payable to the Company’s auditor for the audit of the Company’s subsidiaries, pursuant to legislation | 1.7 | 1.7 |
Total audit-related fees | 2.5 | 2.4 |
| Fees payable to the Company’s auditor for other services: | ||
| – audit-related assurance services | 0.1 | 0.1 |
| – other non-audit services | 0.1 | 0.2 |
2.7 | 2.7 |
| Total continuing and | ||||
| Continuing operations | discontinued operations | |||
| 2023 | 2022 | 2023 | 2022 | |
| £m | £m | £m | £m | |
Wages and salaries | 453.0 | 414.4 | 453.0 | 433.0 |
Social security costs | 78.5 | 68.3 | 78.5 | 72.6 |
| Defined benefit pension plans: | ||||
– current service cost (see note 19) | 0.7 | 0.4 | 0.7 | 0.4 |
– past service credit (see note 19) | (0.1) | (0.1) | (0.1) | (0.1) |
Defined contribution pension plans | 22.9 | 20.0 | 22.9 | 20.1 |
Equity-settled share-based payment expense | 13.1 | 10.1 | 13.1 | 10.3 |
Cash-settled share-based payment expense | 1.1 | 0.9 | 1.1 | 0.8 |
569.2 | 514.0 | 569.2 | 537.1 |
| Total continuing and | ||||
| Continuing operations | discontinued operations | |||
| 2023 | 2022 | 2023 | 2022 | |
| Average number of employees | Number | Number | Number | Number |
Production and engineering | 3,569 | 3,642 | 3,569 | 3,844 |
Sales, marketing and service | 2,767 | 2,764 | 2,767 | 2,860 |
Administrative | 930 | 870 | 930 | 900 |
7,266 | 7,276 | 7,266 | 7,604 |
| 2023 | 2022 | |
| Directors’ remuneration | £m | £m |
Short-term benefits | 3.1 | 2.8 |
Equity-settled share-based payment expense | 2.0 | 1.6 |
5.1 | 4.4 |
| 2023 | 2022 | |
| Financial income from continuing operations | £m | £m |
Interest receivable | (5.3) | (1.9) |
Net gain on retranslation of short-term inter-company loan balances | (5.7) | – |
(11.0) | (1.9) |
| 2023 | 2022 | |
| Finance costs from continuing operations | £m | £m |
Interest payable on loans and overdrafts | 1.4 | 1.8 |
Net loss on retranslation of short-term inter-company loan balances | – | 14.6 |
Unwinding of discount factor on lease liabilities | 2.4 | 2.5 |
Net interest cost on pension plan obligations | 0.3 | 0.3 |
4.1 | 19.2 | |
Net finance (credit)/costs from continuing operations | (6.9) | 17. 3 |
2023 | 2022 | |||||
| UK | Overseas | Total | UK | Overseas | Total | |
| £m | £m | £m | £m | £m | £m | |
Current tax charge | 5.3 | 54.3 | 59.6 | 4.8 | 41.2 | 46.0 |
Adjustments in respect of current tax of prior years | (0.5) | (0.3) | (0.8) | (1.4) | (1.4) | (2.8) |
Deferred tax – origination and reversal of temporary | ||||||
differences (note 20) | (1.9) | (16.7) | (18.6) | (1.3) | (5.2) | (6.5) |
Taxation charge from continuing operations | 2.9 | 37.3 | 40.2 | 2.1 | 34.6 | 36.7 |
| 2023 | 2022 | |
| £m | £m | |
Profit before taxation from continuing operations | 185.6 | 151.5 |
Corporation tax charge at standard rate of 24.2% (2022: 23.8%) | 44.9 | 36.1 |
Permanent tax differences on loss/(profit) on disposal of businesses | 2.8 | (0.1) |
Other non-deductible expenditure | 4.5 | 9.1 |
Tax credits and incentives | (9.9) | (7.6) |
Adjustments to prior year current and deferred tax charges | (2.1) | (0.8) |
Taxation charge | 40.2 | 36.7 |
| 2023 | 2022 | |
| Tax on items recognised directly in the Consolidated Statement of Comprehensive Income | £m | £m |
| Tax charge on net gain on effective portion of changes in fair value of forward | ||
exchange contracts | 1.1 | – |
Tax (credit)/charge on investment in equity instruments designated as at fair value through other comprehensive income | (0.1) | 0.6 |
Tax (credit)/charge on re-measurement of net defined benefit obligations, net of foreign exchange | (0.1) | 3.4 |
| Aggregate current and deferred tax charge relating to items recognised directly | ||
in the Consolidated Statement of Comprehensive Income | 0.9 | 4.0 |
| 2023 | 2022 | |
| Tax on items recognised directly in the Consolidated Statement of Changes in Equity | £m | £m |
Tax credit in relation to share-based payments | (3.2) | (0.2) |
| Aggregate current and deferred tax credit relating to items recognised directly | ||
in the Consolidated Statement of Changes in Equity | (3.2) | (0.2) |
| Tax on items of income and expense that are excluded | 2023 | 2022 |
| from the Group’s adjusted profit before tax | £m | £m |
| Tax credit on amortisation of acquisition-related intangible assets and impairment | ||
of other property, plant and equipment | (4.7) | (4.6) |
Tax credit on net transaction-related costs and fair value adjustments | (1.7) | (0.5) |
Tax charge on retranslation of short-term inter-company loan balances | 0.3 | 0.6 |
Tax credit on loss on disposal of businesses | (0.2) | – |
Tax credit on configuration and customisation costs carried out by third parties on material SaaS projects | (10.8) | (5.1) |
Tax charge/(credit) on fair value through profit and loss movements on debt and equity investments | 0.6 | (1.4) |
Total tax credit | (16.5) | (11.0) |
| 2023 | 2022 | |
| Reconciliation of the statutory taxation charge to the adjusted taxation charge | £m | £m |
Statutory taxation charge | 40.2 | 36.7 |
| Tax credit on items of income and expense that are excluded from the Group’s | ||
adjusted profit before tax | 16.5 | 11.0 |
Adjusted taxation charge | 56.7 | 47.7 |
| 2023 | 2022 | |
| Amounts recognised and paid as distributions to owners of the Company in the year | £m | £m |
| Interim dividend for the year ended 31 December 2023 of 25.3p (2022: 24.1p) | ||
per share | 26.0 | 25.3 |
Final dividend for the year ended 31 December 2022 of 51.3p (2022: 48.8p) per share | 53.7 | 53.3 |
79.7 | 78.6 |
| 2023 | 2022 | |
| Amounts arising in respect of the year | £m | £m |
| Interim dividend for the year ended 31 December 2023 of 25.3p (2022: 24.1p) | ||
per share | 26.0 | 25.3 |
| Proposed final dividend for the year ended 31 December 2023 of 53.9p (2022: 51.3p) | ||
per share | 54.8 | 53.6 |
80.8 | 78.9 |
Basic earnings per share from continuing operations | 2023 | 2022 |
Profit after tax from continuing operations (£m) | 145.4 | 114.8 |
Weighted average number of shares outstanding (millions) | 103.6 | 107.6 |
Basic earnings per share from continuing operations (pence) | 140.3 | 106.7 |
Diluted earnings per share from continuing operations | 2023 | 2022 |
Profit after tax from continuing operations (£m) | 145.4 | 114.8 |
Basic weighted average number of shares outstanding (millions) | 103.6 | 107.6 |
Weighted average number of dilutive 5p ordinary shares under option (millions) | 0.9 | 0.9 |
Weighted average number of 5p ordinary shares that would have been issued at average market value from proceeds of dilutive share options (millions) | (0.2) | (0.2) |
Diluted weighted average number of shares outstanding (millions) | 104.3 | 108.3 |
Diluted earnings per share from continuing operations (pence) | 139.4 | 106.0 |
Basic earnings per share from discontinued operations | 2023 | 2022 |
Profit after tax from discontinued operations (£m) | – | 286.7 |
Weighted average number of shares outstanding (millions) | 103.6 | 107.6 |
Basic earnings per share from discontinued operations (pence) | – | 266.4 |
Diluted earnings per share from discontinued operations | 2023 | 2022 |
Profit after tax from discontinued operations (£m) | – | 286.7 |
Diluted weighted average number of shares outstanding (millions) | 104.3 | 108.3 |
Diluted earnings per share from discontinued operations (pence) | – | 264.7 |
| Patents, | Customer- | |||||
| contractual | related and | |||||
| rights and | trade | |||||
| Goodwill | technology | names | Software | Total | ||
Cost | Note | £m | £m | £m | £m | £m |
At 1 January 2022 | 788.9 | 162.0 | 226.8 | 54.3 | 1,232.0 | |
| Measurement period | ||||||
adjustments | (0.8) | – | – | – | (0.8) | |
| Additions – separately | ||||||
acquired | – | – | – | 1.0 | 1.0 | |
| Additions – internal | ||||||
development | – | 3.4 | – | – | 3.4 | |
| Additions – business | ||||||
combinations | 23 | 49.7 | 22.9 | 36.5 | – | 109.1 |
Reclassifications | – | – | – | 0.3 | 0.3 | |
Disposals | – | – | – | (1.3) | (1.3) | |
Disposals of business | 24 | (213.4) | (36.9) | (81.4) | (8.0) | (339.7) |
| Foreign exchange | ||||||
difference | 57.9 | 16.9 | 20.1 | 2.6 | 97. 5 | |
At 31 December 2022 | 682.3 | 168.3 | 202.0 | 48.9 | 1,101.5 | |
| Additions – separately | ||||||
acquired | – | – | – | 0.8 | 0.8 | |
| Additions – internal | ||||||
development | – | 3.2 | – | – | 3.2 | |
| Additions – business | ||||||
combinations | 23 | 24.6 | 6.9 | 14.8 | – | 46.3 |
Reclassifications | – | – | – | 1.9 | 1.9 | |
Transfers to assets held for sale | 24 | (46.0) | (11.0) | (3.1) | (2.8) | (62.9) |
Disposals | – | – | (0.4) | (7. 3) | (7.7) | |
Disposals of business | 24 | (38.6) | (11.8) | (40.6) | (0.1) | (91.1) |
| Foreign exchange | ||||||
difference | (16.2) | (4.6) | (8.0) | (0.9) | (29.7) | |
At 31 December 2023 | 606.1 | 151.0 | 164.7 | 40.5 | 962.3 |
| Patents, | Customer- | |||||
| contractual | related and | |||||
| rights and | trade | |||||
| Accumulated amortisation and | Goodwill | technology | names | Software | Total | |
impairment | Note | £m | £m | £m | £m | £m |
At 1 January 2022 | 157.5 | 102.5 | 125.3 | 46.2 | 431.5 | |
Charge for the year | – | 15.4 | 7.7 | 3.2 | 26.3 | |
Disposals | – | – | – | (1.3) | (1.3) | |
Disposals of business | 24 | (92.1) | (36.9) | (42.9) | (6.6) | (178.5) |
Foreign exchange difference | 10.8 | 10.2 | 9.9 | 2.4 | 33.3 | |
At 31 December 2022 | 76.2 | 91.2 | 100.0 | 43.9 | 311.3 | |
Charge for the year | – | 15.1 | 7. 2 | 2.6 | 24.9 | |
Reclassifications | – | – | – | 0.1 | 0.1 | |
Transfers to assets held for sale | 24 | – | (4.5) | (0.7) | (2.8) | (8.0) |
Disposals | – | – | (0.4) | (7.3) | (7.7) | |
Disposals of business | 24 | (35.1) | (9.7) | (38.7) | – | (83.5) |
Foreign exchange difference | (0.5) | (3.4) | (2.8) | (0.7) | (7.4) | |
At 31 December 2023 | 40.6 | 88.7 | 64.6 | 35.8 | 229.7 | |
| Carrying amount | ||||||
At 31 December 2023 | 565.5 | 62.3 | 100.1 | 4.7 | 732.6 | |
At 31 December 2022 | 606.1 | 77.1 | 102.0 | 5.0 | 790.2 |
| 2023 | 2022 | |
| £m | £m | |
Malvern Panalytical | 235.8 | 234.6 |
Spectris Dynamics | 294.9 | 290.4 |
Non-significant CGUs | 34.8 | 81.1 |
565.5 | 606.1 |
| Risk Adjusted | Short-term | |||
| discount rates | growth rates | |||
| 2023 | 2022 | 2023 | 2022 | |
| % | % | % | % | |
Malvern Panalytical | 14.6 | 13.5 | 9.8 | 7.6 |
Spectris Dynamics | 14.7 | 14.1 | 9.4 | 8.3 |
Non-significant CGUs | 15.9 | 15.0 | 10.1 | 13.0 |
| Freehold | Leasehold | Plant and | |||
| property | property | equipment | Total | ||
Cost | Note | £m | £m | £m | £m |
At 1 January 2022 | 131.1 | 25.0 | 197.6 | 353.7 | |
Additions – separately acquired | 19.0 | 2.5 | 18.9 | 40.4 | |
Additions – business combinations | 23 | 1.0 | 0.6 | 1.4 | 3.0 |
Reclassifications | – | – | (0.3) | (0.3) | |
Transfer to assets held for sale | 24 | (3.3) | – | – | (3.3) |
Disposals | (0.6) | (0.7) | (6.8) | (8.1) | |
Disposal of business | 24 | (17.3) | (1.8) | (14.4) | (33.5) |
Foreign exchange difference | 9.2 | 1.6 | 11.2 | 22.0 | |
At 31 December 2022 | 139.1 | 27.2 | 207.6 | 373.9 | |
Additions – separately acquired | 2.7 | 1.9 | 16.0 | 20.6 | |
Additions – business combinations | 23 | – | – | 0.7 | 0.7 |
Reclassifications | (4.5) | 4.7 | (2.1) | (1.9) | |
Transfers to assets held for sale | 24 | (6.3) | (1.4) | (9.2) | (16.9) |
Disposals | (3.9) | (1.0) | (21.9) | (26.8) | |
Disposal of business | 24 | (4.1) | (0.3) | (13.5) | (17.9) |
Foreign exchange difference | (3.7) | (1.0) | (5.5) | (10.2) | |
At 31 December 2023 | 119.3 | 30.1 | 172.1 | 321.5 | |
| Accumulated depreciation and impairment | |||||
At 1 January 2022 | 50.4 | 13.1 | 139.7 | 203.2 | |
Charge for the year | 3.5 | 2.5 | 14.6 | 20.6 | |
Reclassifications | – | 0.1 | – | 0.1 | |
Transfers to assets held for sale | 24 | (1.6) | – | – | (1.6) |
Disposals | – | (0.7) | (6.0) | (6.7) | |
Disposal of business | 24 | (3.4) | (1.2) | (10.2) | (14.8) |
Foreign exchange difference | 3.2 | 0.8 | 8.4 | 12.4 | |
At 31 December 2022 | 52.1 | 14.6 | 146.5 | 213.2 | |
Charge for the year | 3.4 | 2.3 | 13.7 | 19.4 | |
Reclassifications | (1.0) | 1.0 | (0.1) | (0.1) | |
Transfers to assets held for sale | 24 | (0.3) | (1.3) | (7.0) | (8.6) |
Disposals | (3.5) | (0.9) | (21.4) | (25.8) | |
Disposal of business | 24 | (1.7) | (0.1) | (4.7) | (6.5) |
Foreign exchange difference | (1.4) | (0.8) | (4.1) | (6.3) | |
At 31 December 2023 | 47.6 | 14.8 | 122.9 | 185.3 | |
| Carrying amount | |||||
At 31 December 2023 | 71.7 | 15.3 | 49.2 | 136.2 | |
At 31 December 2022 | 87.0 | 12.6 | 61.1 | 160.7 |
| Plant and | ||||
| Property | equipment | Total | ||
| Note | £m | £m | £m | |
At 1 January 2022 | 54.7 | 5.8 | 60.5 | |
Additions | 9.2 | 3.9 | 13.1 | |
Depreciation and impairment | (10.2) | (4.0) | (14.2) | |
Disposals | (2.2) | (0.3) | (2.5) | |
Disposal of business | 24 | (1.8) | – | (1.8) |
Additions – business combinations | 23 | 1.0 | – | 1.0 |
Re-measurement | – | 0.2 | 0.2 | |
Foreign exchange difference | 3.1 | 0.3 | 3.4 | |
At 31 December 2022 | 53.8 | 5.9 | 59.7 | |
Additions | 10.6 | 5.4 | 16.0 | |
Depreciation and impairment | (9.5) | (3.9) | (13.4) | |
Disposals | (0.1) | (0.4) | (0.5) | |
Disposal of business | 24 | (3.2) | – | (3.2) |
Transfers to assets held for sale | 24 | (0.8) | – | (0.8) |
Additions – business combinations | 23 | 1.1 | – | 1.1 |
Re-measurement | – | 0.4 | 0.4 | |
Foreign exchange difference | (1.1) | (0.1) | (1.2) | |
At 31 December 2023 | 50.8 | 7.3 | 58.1 |
| 2023 | 2022 | |
| £m | £m | |
Property, plant and equipment: owned | 136.2 | 160.7 |
Property, plant and equipment: right-of-use | 58.1 | 59.7 |
194.3 | 220.4 |
| 2023 | 2022 | |
| £m | £m | |
Investments in equity instruments designated as at fair value through other comprehensive income | 24.3 | 29.3 |
Total investment in equity instruments at 31 December | 24.3 | 29.3 |
| Country of incorporation | Percentage | ||
Name of associates | Principal activity | or registration | shareholding |
CM Labs Simulations Inc. | Manufacturer of turnkey solutions | Canada | 19.4% |
LumaCyte Incorporated | Bioanalytic instrumentation | United States | 12.2% |
| 2023 | 2022 | |
| £m | £m | |
At 1 January | 2.9 | – |
Arising on acquisition of associates | 7.8 | 2.9 |
Share of loss of associates | (0.1) | – |
Foreign exchange difference | 0.2 | – |
At 31 December | 10.8 | 2.9 |
| Country of incorporation | Percentage | ||
Name of joint operation | Principal activity | or registration | shareholding |
Blueberry d.o.o. | Research and development activities | Slovenia | 50% |
| 2023 | 2022 | |
| £m | £m | |
Raw materials | 110.3 | 129.1 |
Work in progress | 43.5 | 49.0 |
Finished goods and goods held for resale | 78.0 | 85.2 |
231.8 | 263.3 |
| 2023 | 2022 | |
| Current | £m | £m |
Trade receivables | 239.5 | 283.3 |
Prepayments | 27.6 | 28.8 |
VAT and similar taxes receivable | 32.2 | 27.2 |
Research and development credits recoverable | 1.6 | 2.9 |
Deferred and contingent consideration on acquisitions | 0.5 | – |
Other receivables | 8.6 | 10.1 |
Contract assets | 7.9 | 10.2 |
317.9 | 362.5 |
| 2023 | 2022 | |
| Non-current | £m | £m |
Prepayments | 3.7 | 2.3 |
Other receivables | 2.2 | 1.9 |
5.9 | 4.2 |
| 2023 | 2022 | |
| £m | £m | |
UK | 9.1 | 9.8 |
Germany | 19.0 | 23.8 |
France | 15.7 | 16.7 |
Rest of Europe | 43.9 | 46.1 |
USA | 55.3 | 77.1 |
Rest of North America | 8.3 | 9.8 |
Japan | 14.8 | 15.0 |
China | 20.2 | 25.0 |
South Korea | 8.6 | 9.5 |
Rest of Asia | 30.5 | 37.1 |
Rest of the world | 14.1 | 13.4 |
239.5 | 283.3 |
2023 | 2022 | |||
| Gross | Impairment | Gross | Impairment | |
| £m | £m | £m | £m | |
Not past due | 161.4 | – | 199.0 | – |
One month past due | 33.6 | – | 36.3 | – |
Two months past due | 15.6 | – | 14.7 | – |
Three months past due | 7. 3 | – | 10.5 | – |
Four months past due | 5.7 | – | 5.6 | – |
More than four months past due | 23.4 | 7.5 | 22.5 | 5.3 |
247.0 | 7. 5 | 288.6 | 5.3 |
| 2023 | 2022 | |
| £m | £m | |
At 1 January | 5.3 | 6.1 |
Provision for impairment of receivables | 2.9 | 0.2 |
Impairment loss utilised | (0.5) | (1.1) |
Disposal of business | (0.1) | (0.4) |
Foreign exchange difference | (0.1) | 0.5 |
At 31 December | 7.5 | 5.3 |
| 2023 | 2022 | ||
| Note | £m | £m | |
Cash and cash equivalents included in current assets | 138.5 | 228.1 | |
Cash and cash equivalents included in assets held for sale | 24 | 0.3 | – |
Cash and cash equivalents | 138.8 | 228.1 |
| 2023 | 2022 | |||
Current | Interest rate | Repayable date | £m | £m |
Bank overdrafts | On demand | – | 0.1 | |
| Bank loans unsecured – £45.0m | Determined on | |||
| (2022: £45.0m) uncommitted facility | draw down | On demand | – | – |
Total current borrowings | – | 0.1 |
| 2023 | 2022 | |||
Non-current | Interest rate | Maturity date | £m | £m |
| Bank loans unsecured – $500.0m | Relevant RFR/ | |||
| revolving credit facilities | IBOR +55bps | 31 July 2025 | – | – |
Total non-current borrowings | – | – | ||
Total current and non-current borrowings | – | 0.1 | ||
Total unsecured borrowings | – | 0.1 |
| 2023 | 2022 | |
| £m | £m | |
At 1 January | 0.1 | – |
Proceeds from borrowings | – | 326.2 |
Repayment of borrowings | (0.1) | (326.8) |
Effect of foreign exchange rates | – | 0.7 |
At 31 December | – | 0.1 |
| At 31 December | Financing cash | Acquisitions of | Disposal of | Other non-cash | Exchange | At 31 December | |||
£m | Note | 2022 | flows | New leases | businesses | businesses | movement | movement | 2023 |
Bank overdrafts (including notional cash-pool related bank overdrafts) | 15 | 0.1 | (0.1) | – | – | – | – | – | – |
Total borrowings | 0.1 | (0.1) | – | – | – | – | – | – | |
| Lease liabilities (including lease liabilities classified as liabilities held for sale) | 65.1 | (15.6) | 16.1 | 1.0 | (3.6) | 2.1 | (1.6) | 63.5 | |
Total liabilities from financing arrangements | 65.2 | (15.7) | 16.1 | 1.0 | (3.6) | 2.1 | (1.6) | 63.5 |
| At 31 December | Financing cash | Acquisitions of | Disposal of | Other non-cash | Exchange | At 31 December | |||
£m | Note | 2021 | flows | New leases | businesses | businesses | movement | movement | 2022 |
Bank overdrafts (including notional cash-pool related bank overdrafts) | 15 | – | 0.1 | – | – | – | – | – | 0.1 |
Debt | – | (0.7) | – | 0.1 | – | (0.1) | 0.7 | – | |
Total borrowings | – | (0.6) | – | 0.1 | – | (0.1) | 0.7 | 0.1 | |
Lease liabilities | 65.9 | (16.4) | 13.2 | 1.0 | (3.2) | 0.3 | 4.3 | 65.1 | |
Total liabilities from financing arrangements | 65.9 | (17.0) | 13.2 | 1.1 | (3.2) | 0.2 | 5.0 | 65.2 |
| 2023 | 2022 | |
| Current | £m | £m |
Trade payables | 42.8 | 62.8 |
Accruals | 114.9 | 114.0 |
Customer advances | 31.8 | 48.5 |
Contract liabilities | 85.5 | 98.4 |
Deferred and contingent consideration on acquisitions | 10.6 | 3.3 |
VAT and similar taxes payable | 27.6 | 27.0 |
Goods received not invoiced | 7.9 | 14.9 |
Share buyback accrual | 45.9 | – |
Other payables | 2.4 | 4.8 |
369.4 | 373.7 |
| 2023 | 2022 | |
| Non-current | £m | £m |
Contract liabilities | 4.0 | 3.9 |
Accruals | 11.1 | 9.9 |
15.1 | 13.8 |
| 2023 | 2022 | |
| £m | £m | |
Spectris Scientific | 58.0 | 71.5 |
Spectris Dynamics | 31.4 | 30.6 |
Others | 0.1 | 0.2 |
89.5 | 102.3 |
| Legal, | |||||
| Product | contractual | ||||
| Reorganisation | warranty | and other | Total | ||
| Note | £m | £m | £m | £m | |
At 1 January 2023 | 3.1 | 7.0 | 7.1 | 17. 2 | |
| Balance transferred to Defined Benefit | |||||
Obligation Plans | – | – | (1.4) | (1.4) | |
Provision during the year | 0.5 | 5.2 | 1.5 | 7.2 | |
Disposal of business | 24 | – | – | (0.4) | (0.4) |
Utilised during the year | (2.8) | (4.4) | (2.2) | (9.4) | |
Released during the year | (0.1) | (0.2) | (0.4) | (0.7) | |
Transfer to liabilities held for sale | – | (0.7) | (0.2) | (0.9) | |
Foreign exchange difference | (0.1) | (0.2) | (0.2) | (0.5) | |
At 31 December 2023 | 0.6 | 6.7 | 3.8 | 11.1 |
2023 | 2022 | |||
| Overseas | Overseas | |||
| UK plan | plans | UK plan | plans | |
| % p.a. | % p.a. | % p.a. | % p.a. | |
Discount rate | 4.54 | 1.35–3.30 | 4.85 | 2.15–3.80 |
Salary increases | n/a | 1.50–3.00 | n/a | 1.50–3.00 |
Pension increases in payment | 1.95 –3.62 | 0.00–2.25 | 2.30–3.41 | 0.00–2.25 |
Pension increases in deferment | 2.52–2.95 | n/a | 2.55–3.02 | n/a |
Inflation assumption | 2.52–2.95 | 1.25–3.5 | 2.55–3.02 | 1.25–3.50 |
Interest credit rate | n/a | 1.00 | n/a | 1.00 |
UK plan | 103% and 106% of the S3PA tables centred in 2013 for males and females respectively. |
| Future improvements in line with the core CMI_2022 model subject to a long-term | |
| improvement rate of 1.25% per annum, an initial addition of 0.2% and a 25% weighting on | |
| 2022 mortality experience. | |
French plans | INSEE tables (2013, 2017-2019 or 2018-2020 depending on plan) |
German plans | Dr K Heubeck pension tables 2018 G |
Dutch plans | A.G. Prognosetafel 2018 tables |
Swiss plan | BVG 2020 – CMI 1.50% |
Italian plans | SI 2019 |
Male | Female | |
Pensioners aged 65 in 2023 | 85.8 –87.0 | 88.6–89.2 |
Pensioners aged 65 in 2043 | 87.6 –89.0 | 90.0–91.4 |
UK plan | Overseas plans | Total | ||||
| Amounts recognised in the | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| Consolidated Income Statement | £m | £m | £m | £m | £m | £m |
Current service cost | – | – | 0.7 | 0.4 | 0.7 | 0.4 |
Past service credit | – | – | (0.1) | (0.1) | (0.1) | (0.1) |
Administrative cost | – | – | 0.1 | – | 0.1 | – |
Settlement/curtailment | – | – | – | (0.1) | – | (0.1) |
Net interest cost | – | 0.2 | 0.3 | 0.1 | 0.3 | 0.3 |
– | 0.2 | 1.0 | 0.3 | 1.0 | 0.5 |
| Amounts recognised in the | UK plan | Overseas plans | Total | |||
| Consolidated Statement | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| of Comprehensive Income | £m | £m | £m | £m | £m | £m |
Actuarial gains/(losses) recognised in the current year | 1.4 | 9.8 | (2.0) | 3.3 | (0.6) | 13.1 |
Foreign exchange gains/(losses) in the current year | – | – | 0.2 | (0.7) | 0.2 | (0.7) |
Total gains/(losses) recognised in the current year | 1.4 | 9.8 | (1.8) | 2.6 | (0.4) | 12.4 |
| Amounts recognised in the | UK plan | Overseas plans | Total | |||
| Consolidated Statement of | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| Financial Position | £m | £m | £m | £m | £m | £m |
Present value of defined benefit obligations | (91.0) | (90.6) | (27.0) | (22.4) | (118.0) | (113.0) |
Fair value of plan assets | 93.4 | 90.4 | 15.4 | 13.7 | 108.8 | 104.1 |
Net surplus/(deficit) in plans | 2.4 | (0.2) | (11.6) | (8.7) | (9.2) | (8.9) |
UK plan | Overseas plans | Total | ||||
| Reconciliation of | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| movement in net deficit | £m | £m | £m | £m | £m | £m |
At 1 January | (0.2) | (11.0) | (8.7) | (11.3) | (8.9) | (22.3) |
| Balance transferred from other operating | ||||||
provisions | – | – | (1.4) | – | (1.4) | – |
Current service cost | – | – | (0.7) | (0.4) | (0.7) | (0.4) |
Net interest cost | – | (0.2) | (0.3) | (0.1) | (0.3) | (0.3) |
Plan administrative cost | – | – | (0.1) | – | (0.1) | – |
Settlement/curtailment | – | – | – | 0.1 | – | 0.1 |
Acquisitions of businesses | – | – | – | (0.5) | – | (0.5) |
Past service credit | – | – | 0.1 | 0.1 | 0.1 | 0.1 |
| Contributions from sponsoring company | ||||||
and plan members | 1.2 | 1.2 | 0.7 | 0.3 | 1.9 | 1.5 |
Benefits paid | – | – | 0.6 | 0.5 | 0.6 | 0.5 |
Actuarial gains/(losses) | 1.4 | 9.8 | (2.0) | 3.3 | (0.6) | 13.1 |
Foreign exchange difference | – | – | 0.2 | (0.7) | 0.2 | (0.7) |
At 31 December | 2.4 | (0.2) | (11.6) | (8.7) | (9.2) | (8.9) |
| Analysis of movement in the | UK plan | Overseas plans | Total | |||
| present value of the defined benefit | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| obligation | £m | £m | £m | £m | £m | £m |
At 1 January | 90.6 | 133.2 | 22.4 | 26.5 | 113.0 | 159.7 |
| Balance transferred from other operating | ||||||
provisions | – | – | 1.3 | – | 1.3 | – |
Current service cost | – | – | 0.7 | 0.4 | 0.7 | 0.4 |
Interest cost | 4.3 | 2.4 | 0.7 | 0.2 | 5.0 | 2.6 |
Settlement/curtailment | – | – | – | (0.1) | – | (0.1) |
Acquisitions of businesses | – | – | – | 2.6 | – | 2.6 |
Past service credit | – | – | (0.1) | (0.1) | (0.1) | (0.1) |
Contributions from plan members | – | – | 0.4 | 0.2 | 0.4 | 0.2 |
Actuarial losses/(gains) – financial | 1.9 | (44.5) | 1.8 | (7.7) | 3.7 | (52.2) |
Actuarial (gains)/losses – demographic | (0.9) | (1.2) | – | – | (0.9) | (1.2) |
Actuarial losses/(gains) – experience | 0.5 | 6.0 | 0.5 | (0.1) | 1.0 | 5.9 |
Benefits paid | (5.4) | (5.3) | (0.8) | (1.4) | (6.2) | (6.7) |
Foreign exchange difference | – | – | 0.1 | 1.9 | 0.1 | 1.9 |
At 31 December | 91.0 | 90.6 | 27.0 | 22.4 | 118.0 | 113.0 |
| Analysed as: | ||||||
| Present value of unfunded defined benefit | ||||||
obligation | – | – | 8.9 | 5.0 | 8.9 | 5.0 |
| Present value of funded defined benefit | ||||||
obligation | 91.0 | 90.6 | 18.1 | 17.4 | 109.1 | 108.0 |
UK plan | Overseas plans | Total | ||||
| Reconciliation of movement | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| in fair value of plan assets | £m | £m | £m | £m | £m | £m |
At 1 January | 90.4 | 122.2 | 13.7 | 15.2 | 104.1 | 137.4 |
Interest income on assets | 4.3 | 2.2 | 0.4 | 0.1 | 4.7 | 2.3 |
Plan administration cost | – | – | (0.1) | – | (0.1) | – |
Acquisitions of businesses | – | – | – | 2.1 | 0.0 | 2.1 |
Contributions from sponsoring company | 1.2 | 1.2 | 0.7 | 0.3 | 1.9 | 1.5 |
Contributions from plan members | – | – | 0.4 | 0.2 | 0.4 | 0.2 |
Actuarial gains/(losses) | 2.9 | (29.9) | 0.4 | (4.5) | 3.3 | (34.4) |
Benefits paid | (5.4) | (5.3) | (0.2) | (0.9) | (5.6) | (6.2) |
Foreign exchange difference | – | – | 0.1 | 1.2 | 0.1 | 1.2 |
At 31 December | 93.4 | 90.4 | 15.4 | 13.7 | 108.8 | 104.1 |
UK plan | Overseas plans | Total | ||||
| 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |
| Fair value of assets | £m | £m | £m | £m | £m | £m |
Equity instruments | 3.0 | 1.7 | – | – | 3.0 | 1.7 |
Corporate bonds | 71.5 | 67.1 | – | – | 71.5 | 67.1 |
Government bonds | 14.0 | 12.5 | – | – | 14.0 | 12.5 |
Cash and financial derivatives and other (net) | 4.8 | 9.0 | – | – | 4.8 | 9.0 |
Insurance policies | 0.1 | 0.1 | 15.4 | 13.7 | 15.5 | 13.8 |
93.4 | 90.4 | 15.4 | 13.7 | 108.8 | 104.1 |
UK plan | Overseas plans | |||
| 2023 | 2022 | 2023 | 2022 | |
| Asset class | % | % | % | % |
i. Equity | 3.2 | 1.9 | – | – |
ii. Corporate Bonds | 76.6 | 74.2 | – | – |
iii. Government Bonds | 15.0 | 13.8 | – | – |
iv. Cash and financial derivatives and other (net) | 5.1 | 10.0 | – | – |
v. Insurance contracts | 0.1 | 0.1 | 100.0 | 100.0 |
100.0 | 100.0 | 100.0 | 100.0 |
| Impact on plan liabilities as at 31 December 2023 | |||
| Change in | UK plan | Overseas plans | |
| assumption | £m | £m | |
Discount rate | +1.00% | (9.2) | (3.0) |
Rate of price inflation (RPI) | +1.00% | 3.0 | 1.6 |
Assumed life expectancy at age 65 | +1 year | 2.5 | 0.7 |
| 2023 | 2022 | ||
| Note | £m | £m | |
At 1 January | (0.6) | 1.8 | |
Measurement period adjustments | – | (1.4) | |
Foreign exchange difference | 0.3 | 2.0 | |
Acquisition of subsidiary undertakings | 23 | 0.6 | 2.5 |
Disposal of businesses | (0.6) | (8.6) | |
Transfer of liabilities held for sale | (6.0) | – | |
| Deferred tax on changes in fair value of forward exchange contracts | |||
recognised in the Consolidated Statement of Comprehensive Income | 0.9 | (0.1) | |
| Deferred tax on re-measurement of net defined benefit liability | |||
recognised in the Consolidated Statement of Comprehensive Income | 0.3 | 3.4 | |
Deferred tax on share-based payments recognised in equity | (1.6) | (0.1) | |
Deferred tax charge on discontinued operations | – | 6.4 | |
Credited to the Consolidated Income Statement | 7 | (18.6) | (6.5) |
At 31 December | (25.3) | (0.6) | |
| Comprising: | |||
Deferred tax liabilities | 1.3 | 15.6 | |
Deferred tax assets | (26.6) | (16.2) | |
(25.3) | (0.6) |
| Unrealised profit | Goodwill and | |||||||
| Accelerated tax | Accruals and | on inter-company | other intangible | 2023 | ||||
| depreciation | provisions | Tax losses | transactions | Pension plans | assets | Other | Total | |
| Net deferred tax (assets)/liabilities | £m | £m | £m | £m | £m | £m | £m | £m |
At 1 January 2023 | 2.1 | (23.4) | (4.3) | (10.5) | (2.7) | 35.1 | 3.1 | (0.6) |
Foreign exchange difference | – | – | – | 0.6 | – | (0.3) | – | 0.3 |
Acquisition of subsidiary undertakings | – | – | – | – | – | 0.6 | – | 0.6 |
Disposal of businesses | – | – | – | – | – | (0.6) | – | (0.6) |
Transfer of liabilities held for sale | (0.8) | 2.2 | – | – | – | (7.4) | – | (6.0) |
Deferred tax on changes in fair value of forward exchange contracts recognised in the Consolidated Statement of Comprehensive Income | – | – | – | – | – | – | 0.9 | 0.9 |
Deferred tax on re-measurement of net defined benefit obligation recognised in the Consolidated Statement of Comprehensive Income | – | – | – | – | 0.3 | – | – | 0.3 |
Deferred tax on share-based payments recognised in equity | – | – | – | – | – | – | (1.6) | (1.6) |
(Credited)/charged to the Consolidated Income Statement | – | (8.4) | (0.4) | 0.5 | 0.2 | (2.6) | (7.9) | (18.6) |
At 31 December 2023 | 1.3 | (29.6) | (4.7) | (9.4) | (2.2) | 24.8 | (5.5) | (25.3) |
| Unrealised profit | Goodwill and | |||||||
| Accelerated tax | Accruals and | on inter-company | other intangible | 2022 | ||||
| depreciation | provisions | Tax losses | transactions | Pension plans | assets | Other | Total | |
| Net deferred tax (assets)/liabilities | £m | £m | £m | £m | £m | £m | £m | £m |
At 1 January 2022 | 0.4 | (18.2) | (0.3) | (7.0) | (6.0) | 36.1 | (3.2) | 1.8 |
Measurement period adjustments | (1.4) | (1.4) | ||||||
Foreign exchange difference | – | – | – | – | – | 2.0 | – | 2.0 |
Acquisition of subsidiary undertakings | – | 0.2 | (2.2) | – | (0.1) | 4.6 | – | 2.5 |
Disposal of businesses | 0.1 | 0.6 | – | – | – | (9.3) | – | (8.6) |
Deferred tax on changes in fair value of forward exchange contracts recognised in the Consolidated Statement of Comprehensive Income | – | – | – | – | – | – | (0.1) | (0.1) |
Deferred tax on re-measurement of net defined benefit obligation recognised in the Consolidated Statement of Comprehensive Income | – | – | – | – | 3.4 | – | – | 3.4 |
Deferred tax on share-based payments recognised in equity | – | – | – | – | – | – | (0.1) | (0.1) |
Discontinued Operations deferred tax charge | 0.1 | 0.4 | – | – | – | 0.1 | 5.8 | 6.4 |
Charge/(credited) to the Consolidated Income Statement | 1.5 | (6.4) | (0.4) | (3.5) | – | 1.6 | 0.7 | (6.5) |
At 31 December 2022 | 2.1 | (23.4) | (4.3) | (10.5) | (2.7) | 35.1 | 3.1 | (0.6) |
| 2023 | 2022 | |
| £m | £m | |
Tax losses | 21.0 | 25.1 |
21.0 | 25.1 |
2023 | 2022 | |||
| Number of | Number of | |||
| shares | shares | |||
Millions | £m | Millions | £m | |
| Issued and fully paid (ordinary shares of 5p each): | ||||
At 1 January and 31 December | 105.8 | 5.3 | 109.1 | 5.5 |
2023 | 2022 | |
| Number | Number | |
| Incentive plan | thousands | thousands |
| Equity-settled: | ||
Long Term Incentive Plan | 1,423 | 1,385 |
Performance Share Plan | 76 | 135 |
Long Term Incentive Plan (Linked tax-advantaged) | 92 | 99 |
Performance Share Plan (Linked tax-advantaged) | 3 | 8 |
Spectris Reward Plan | 183 | 262 |
Deferred Bonus Plan | 57 | 38 |
Total equity-settled | 1,834 | 1,927 |
| Cash-settled: | ||
Long Term Incentive Plan Cash | 64 | 71 |
Spectris Reward Plan Cash | 13 | 15 |
Total cash-settled | 77 | 86 |
Total outstanding | 1,911 | 2,013 |
| Long Term Incentive Plan, | 2023 | 2022 | ||||
| Performance Share Plan, | Weighted | Weighted | ||||
| Spectris Reward Plan and | Remaining | average | average | |||
| Deferred Bonus Plan | contractual | exercise | exercise | |||
| life of | Number | price | Number | price | ||
| Year of grant | options | thousands | £ | thousands | £ | |
2015 | PSP | 2 years | 1 | 0.05 | 1 | 0.05 |
2016 | PSP | 3 years | 6 | 0.05 | 9 | 0.05 |
2017 | PSP | 4 years | 10 | 0.05 | 37 | 0.05 |
2018 | PSP | 5 years | 11 | 0.05 | 26 | 0.05 |
2019 | PSP | 6 years | 48 | 0.05 | 62 | 0.05 |
2020 | LTIP/ SRP | 7 years | 170 | 0.05 | 515 | 0.05 |
2021 | LTIP/ SRP/DBP | 8 years | 428 | 0.05 | 533 | 0.05 |
2022 | LTIP/ SRP/DBP | 9 years | 583 | 0.05 | 637 | 0.05 |
2023 | LTIP/ SRP/DBP | 10 years | 482 | 0.05 | – | – |
1,739 | 0.05 | 1,820 | 0.05 |
2023 | 2022 | |||||
| Weighted | Weighted | Weighted | Weighted | |||
| Long Term Incentive Plan, | average | average | average | average | ||
| Spectris Reward Plan and | exercise | fair value at | exercise | fair value at | ||
| Performance Share Plan | Number | price | grant date | Number | price | grant date |
| (equity awards) | thousands | £ | £ | thousands | £ | £ |
At 1 January | 1,820 | 0.05 | 1,776 | 0.05 | ||
Shares granted | 508 | 0.05 | 30.22 | 711 | 0.05 | 21.13 |
| Addition of reinvested | ||||||
dividends | 38 | – | 17 | – | ||
Exercised | (436) | 0.05 | (166) | 0.05 | ||
Forfeited | (191) | 0.05 | (518) | 0.05 | ||
At 31 December | 1,739 | 0.05 | 1,820 | 0.05 | ||
Exercisable at 31 December | 128 | 0.05 | 120 | 0.05 |
2023 | 2022 | |||||
| Long Term Incentive Plan | Weighted | Weighted | ||||
| and Performance Share Plan | Remaining | average | average | |||
| (Linked tax-advantaged) | contractual | exercise | exercise | |||
| life of | Number | price | Number | price | ||
| Year of grant | options | thousands | £ | thousands | £ | |
2017 | PSP | 4 years | 1 | 26.31 | 1 | 26.31 |
2018 | PSP | 5 years | – | 26.77 | 1 | 25.80 |
2019 | PSP | 6 years | 2 | 26.69 | 5 | 26.69 |
2020 | LTIP | 7 years | 4 | 22.39 | 29 | 22.72 |
2021 | LTIP | 8 years | 27 | 32.01 | 30 | 31.95 |
2022 | LTIP | 9 years | 38 | 26.77 | 41 | 26.76 |
2023 | LTIP | 10 years | 23 | 34.54 | – | – |
95 | 29.99 | 107 | 27.11 |
2023 | 2022 | |||||
| Weighted | Weighted | Weighted | Weighted | |||
| average | average | average | average | |||
| Long Term Incentive Plan and | exercise | fair value at | exercise | fair value at | ||
| Performance Share Plan | Number | price | grant date | Number | price | grant date |
| (Linked tax-advantaged) | thousands | £ | £ | thousands | £ | £ |
At 1 January | 107 | 27.11 | 101 | 27.05 | ||
Shares granted | 28 | 34.55 | 7.84 | 45 | 26.74 | 5.81 |
Exercised | (28) | 23.60 | (6) | 25.99 | ||
Forfeited | (12) | 29.86 | (33) | 26.62 | ||
At 31 December | 95 | 29.99 | 107 | 27.11 | ||
Exercisable at 31 December | 7 | 24.13 | 7 | 26.76 |
| Long Term Incentive Plan, | 2023 | 2022 | ||||
| Spectris Reward Plan and | Weighted | Weighted | ||||
| Performance Share Plan | Remaining | average | average | |||
| (Phantom allocations) | contractual | exercise | exercise | |||
| life of | Number | price | Number | price | ||
| Year of grant | options | thousands | £ | thousands | £ | |
2020 | LTIP/SRP | – | – | – | 28 | 0.05 |
2021 | LTIP/SRP | 1 year | 22 | 0.05 | 27 | 0.05 |
2022 | LTIP/SRP | 2 years | 28 | 0.05 | 31 | 0.05 |
2023 | LTIP/SRP | 3 years | 27 | 0.05 | – | – |
77 | 0.05 | 86 | 0.05 |
2023 | 2022 | |||||
| Weighted | Weighted | |||||
| Long Term Incentive Plan, | average | average | ||||
| Spectris Reward Plan and | fair value at | fair value at | ||||
| Performance Share Plan | Number | Exercise | grant date | Number | Exercise | grant date |
| (Phantom allocations) | thousands | £ | £ | thousands | £ | £ |
At 1 January | 86 | 0.05 | 67 | 0.05 | ||
Shares granted | 30 | 0.05 | 34.64 | 33 | 0.05 | 26.93 |
| Addition of reinvested | ||||||
dividends | 2 | – | – | – | ||
Exercised | (31) | 0.05 | (4) | 0.05 | ||
Forfeited | (10) | 0.05 | (10) | 0.05 | ||
At 31 December | 77 | 0.05 | 86 | 0.05 | ||
Exercisable at 31 December | – | – | – | – |
Equity-settled | Cash-settled | |||||
| Share awards | (Linked tax-advantaged) | |||||
| LTIP & SRP | LTIP & SRP | LTIP Cash & SRP Cash | ||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |
| Weighted average share | ||||||
price at date of grant (£) | 34.68 | 26.94 | 34.60 | 26.97 | 34.69 | 26.98 |
| Weighted average exercise | ||||||
price (£) | 0.05 | 0.05 | 34.55 | 26.74 | 34.61 | 0.05 |
Expected volatility | 26.67% | 28.41% | 26.61% | 28.55% | 26.67% | 28.58% |
Expected life | 3.36 yrs | 3.30 yrs | 3 yrs | 3.07 yrs | 3 yrs | 3 yrs |
Risk-free rate | 3.31% | 1.37% | 3.40% | 1.39% | 3.31% | 1.39% |
| Expected dividends | ||||||
(expressed as a yield) | – | – | – | – | – | – |
Weighted average fair values at date of grant (£): | ||||||
TSR condition | 25.19 | 10.25 | n/a | n/a | n/a | n/a |
ESG condition | 29.49 | n/a | 7.84 | n/a | 34.64 | n/a |
ROGCE condition | 29.49 | 20.38 | 7.84 | 5.81 | 34.64 | 26.91 |
EPS condition | 29.49 | 20.38 | 7.84 | 5.81 | 34.64 | 26.91 |
Service condition | 33.83 | 26.48 | 7.83 | 5.84 | 34.64 | 26.98 |
Weighted average fair values at 31 December (£): | ||||||
ROGCE condition (cash- settled) | 36.86 | 29.09 | ||||
ESG condition (cash-settled) | 36.09 | n/a | ||||
EPS condition (cash-settled) | 36.86 | 29.09 | ||||
| Service condition | ||||||
(cash-settled) | 36.81 | 29.12 |
| 2023 | ||||
| XRD | Total fair | |||
| MicroStrain | EMS | product line | value | |
| £m | £m | £m | £m | |
Intangible assets | 11.2 | 4.5 | 6.0 | 21.7 |
Property, plant and equipment | 0.7 | – | – | 0.7 |
Right-of-use assets | 1.0 | 0.1 | – | 1.1 |
Inventories | 2.8 | 0.2 | – | 3.0 |
Trade and other receivables | 0.2 | 1.4 | – | 1.6 |
Cash and cash equivalents | – | 2.6 | – | 2.6 |
Trade and other payables | (1.0) | (1.5) | – | (2.5) |
Lease liabilities | (1.0) | – | – | (1.0) |
Current tax liabilities | – | (0.1) | – | (0.1) |
Deferred tax liabilities | – | (0.6) | – | (0.6) |
Net assets acquired | 13.9 | 6.6 | 6.0 | 26.5 |
Goodwill | 15.2 | 2.4 | 7.0 | 24.6 |
Gross consideration | 29.1 | 9.0 | 13.0 | 51.1 |
Adjustment for cash acquired | – | (2.6) | – | (2.6) |
Net consideration | 29.1 | 6.4 | 13.0 | 48.5 |
| 2023 | 2022 | |
| Analysis of cash outflow in Consolidated Statement of Cash Flows | £m | £m |
Gross consideration in respect of acquisitions during the year | 51.1 | 116.8 |
Adjustment for net cash acquired | (2.6) | (1.5) |
Net consideration in respect of acquisitions during the year | 48.5 | 115.3 |
| Deferred and contingent consideration on acquisitions included in net | ||
consideration during the year to be paid in future years | (2.5) | (2.2) |
Cash paid during the year in respect of acquisitions during the year | 46.0 | 113.1 |
Cash paid in respect of prior years’ acquisitions | 3.5 | 1.6 |
Net cash outflow relating to acquisitions | 49.5 | 114.7 |
| 2022 | ||||
| Total fair | ||||
| Creoptix | MB connect | Dytran | value | |
| £m | £m | £m | £m | |
Intangible assets | 18.5 | 5.1 | 35.8 | 59.4 |
Property, plant and equipment | 0.1 | 1.2 | 1.7 | 3.0 |
Right of use assets | 1.0 | – | – | 1.0 |
Inventories | 0.6 | 0.3 | 5.2 | 6.1 |
Trade and other receivables | 1.6 | 0.1 | 2.9 | 4.6 |
Cash and cash equivalents | 0.3 | 0.3 | 0.9 | 1.5 |
Borrowings | – | (0.1) | – | (0.1) |
Trade and other payables | (1.9) | (0.1) | (2.3) | (4.3) |
Retirement benefit obligations | (0.5) | – | – | (0.5) |
Lease liabilities | (1.0) | – | – | (1.0) |
Current tax liabilities | – | (0.1) | – | (0.1) |
Deferred tax liabilities | (0.9) | (1.6) | – | (2.5) |
Net assets acquired | 17.8 | 5.1 | 44.2 | 67.1 |
Goodwill | 19.5 | 3.9 | 26.3 | 49.7 |
Gross consideration | 37. 3 | 9.0 | 70.5 | 116.8 |
Adjustment for cash acquired | (0.3) | (0.3) | (0.9) | (1.5) |
Net consideration | 37.0 | 8.7 | 69.6 | 115.3 |
| 2023 | |
| Concept Life | |
| Sciences | |
| £m | |
Goodwill | 3.5 |
Other intangible assets | 4.1 |
Property, plant and equipment – owned and right-of-use assets | 14.6 |
Inventories | 0.6 |
Trade and other receivables | 6.1 |
Cash and cash equivalents | 1.9 |
Trade and other payables | (3.0) |
Lease liabilities | (3.6) |
Current and deferred tax liabilities | (0.6) |
Net assets of disposed businesses | 23.6 |
| Consideration received | |
Settled in cash | 15.5 |
Total consideration received | 15.5 |
Transaction expenses booked to loss on disposal of business | (2.2) |
Net consideration from disposal of business | 13.3 |
Net assets disposed of (including cash and cash equivalents held by disposal group) | (23.6) |
Loss on disposal of business | (10.3) |
| Net proceeds recognised in the Consolidated Statement of Cash Flows | |
Consideration received settled in cash | 15.5 |
Cash and cash equivalents held by disposed business | (1.9) |
Transaction fees paid | (2.2) |
| Net proceeds recognised in the Consolidated Statement of Cash Flows in respect of current | |
year disposals | 11.4 |
Payments made in respect of prior years’ disposals of businesses | (2.2) |
Tax paid on prior year disposal of businesses | (5.9) |
Net proceeds recognised in the Consolidated Statement of Cash Flows | 3.3 |
| 2022 | |
| Omega | |
| £m | |
Goodwill | 121.3 |
Other intangible assets | 39.9 |
Property, plant and equipment – owned and right of use assets | 20.5 |
Current tax assets | 0.1 |
Inventories | 20.8 |
Trade and other receivables | 18.0 |
Cash and cash equivalents | 7.7 |
Trade and other payables | (19.9) |
Lease liabilities | (3.2) |
Current and deferred tax liabilities | (8.6) |
Provisions | (0.2) |
Net assets of disposed businesses | 196.4 |
| Consideration received | |
Settled in cash | 417.9 |
Total consideration received | 417.9 |
Transaction expenses booked to profit on disposal of business | (14.3) |
Net consideration from disposal of business | 403.6 |
Net assets disposed of (including cash and cash equivalents held by disposal group) | (196.4) |
Currency translation differences transferred from translation reserve | 86.7 |
Pre-tax profit on disposal of the Omega reportable segment | 293.9 |
| Net proceeds recognised in the Consolidated Statement of Cash Flows | |
Consideration received settled in cash | 417.9 |
Cash and cash equivalents held by disposed business | (7.7) |
Transaction fees paid | (14.3) |
Tax paid on current year disposal of business | (15.3) |
| Net proceeds recognised in the Consolidated Statement of Cash Flows in respect of current | |
year disposals | 380.6 |
Payments made in respect of prior years’ disposals of businesses | (2.6) |
Tax paid on prior year disposal of businesses | (12.6) |
Net proceeds recognised in the Consolidated Statement of Cash Flows | 365.4 |
| 2022 | |
| £m | |
Revenue | 73.9 |
Expenses included in adjusted operating profit | (59.9) |
Adjusted operating profit | 14.0 |
Other expenses | (1.1) |
Profit before tax | 12.9 |
Attributable tax expense | (2.7) |
| 10.2 | |
Profit on disposal of discontinued operations | 293.9 |
Tax expense attributable to profit on disposal of discontinued operations | (17.4) |
Profit after tax from discontinued operations for the year attributable to owners of the Company | 286.7 |
| 2023 | |
| £m | |
Goodwill | 46.0 |
Other intangible assets | 8.9 |
Property, plant and equipment | 8.3 |
Right-of-use assets | 0.8 |
Inventories | 22.9 |
Trade and other receivables | 10.3 |
Cash and cash equivalents | 0.3 |
Total assets classified as held for sale | 97.5 |
Derivative financial instruments | (0.1) |
Trade and other payables | (9.4) |
Provisions | (0.9) |
Lease liabilities | (0.8) |
Current tax liabilities | (0.6) |
Deferred tax liabilities | (6.0) |
Total liabilities classified as held for sale | (17.8) |
Net assets of disposal group | 79.7 |
| 2023 | 2022 | ||
| Note | £m | £m | |
| Cash flows from operating activities | |||
Profit after tax | 145.4 | 401.5 | |
| Adjustments for: | |||
Taxation charge | 40.2 | 56.8 | |
Share of post-tax results of associates | 0.1 | ||
Loss/(profit) on disposal of businesses | 24 | 12.6 | (294.2) |
Finance costs | 6 | 4.1 | 19.2 |
Financial income | 6 | (11.0) | (1.9) |
Depreciation and impairment of property, plant and equipment | 11 | 32.8 | 34.8 |
Amortisation, impairment and other non-cash adjustments made to intangible assets | 10 | 24.9 | 26.3 |
Transaction-related fair value adjustments | 27 | 7. 5 | 1.0 |
Fair value through profit and loss movements on debt investments | 27 | (2.8) | 4.1 |
Profit on disposal and re-measurements of property, plant and equipment and associated lease liabilities | (0.5) | (1.5) | |
Equity-settled share-based payment expense | 5 | 13.1 | 10.4 |
| Operating cash flow before changes in working capital | |||
and provisions | 266.4 | 256.5 | |
Decrease/(increase) in trade and other receivables | 16.0 | (47.9) | |
Decrease/(increase) in inventories | 1.5 | (75.6) | |
(Decrease)/increase in trade and other payables | (33.0) | 40.9 | |
Decrease in provisions and retirement benefits | (5.4) | (7.1) | |
Cash generated from operations | 245.5 | 166.8 |
| Change in fair value for | ||||
| recognising hedge | Carrying amount of the | |||
| ineffectiveness | hedging instruments | |||
| 2023 | 2022 | 2023 | 2022 | |
| £m | £m | £m | £m | |
| Cash flow hedges | ||||
| Currency risk – forward exchange contracts | ||||
Less than 6 months | 4.2 | (0.8) | 4.2 | (0.8) |
6 to 12 months | 1.5 | (0.1) | 1.5 | (0.1) |
12 to 18 months | 0.3 | 0.1 | 0.3 | 0.1 |
6.0 | (0.8) | 6.0 | (0.8) |
| Balance in cash flow | ||||
| hedge reserve/foreign | ||||
| Change in value used for | currency translation | |||
| calculating hedge | reserve for continuing | |||
| effectiveness | hedges | |||
| 2023 | 2022 | 2023 | 2022 | |
| £m | £m | £m | £m | |
| Currency risk | ||||
| Forecast sales | (6.0) | 0.8 | (6.0) | 0.8 |
| 2023 | 2022 | |
| £m | £m | |
Equity shareholders’ funds | 1,315.9 | 1,436.9 |
Undrawn committed debt facilities | 393.1 | 414.9 |
1,709.0 | 1,851.8 |
| 2023 | ||||
| Level 1 | Level 2 | Level 3 | Carrying | |
| fair value | fair value | fair value | amount | |
| Fair value and carrying amount of financial instruments | £m | £m | £m | £m |
Trade and other receivables excluding prepayments and contract assets | – | – | 0.5 | 284.6 |
| Trade and other payables excluding contract liabilities | ||||
and customer advances | – | – | (10.6) | (263.2) |
| Investments in equity instruments designated at initial | ||||
recognition at fair value through other comprehensive income (see note 12) | 0.4 | – | 23.9 | 24.3 |
Investment in debt instruments | – | – | 21.7 | 21.7 |
| Financial instruments included in assets held for sale (see | ||||
note 24) | – | 0.3 | – | 10.6 |
| Financial instruments included in liabilities held for sale | ||||
(see note 24) | – | (0.1) | (1.3) | (9.5) |
Forward exchange contract assets | – | 6.2 | – | 6.2 |
Cash and cash equivalents | – | 138.5 | – | 138.5 |
Forward exchange contract liabilities | – | (0.1) | – | (0.1) |
| 213.1 |
| 2022 | ||||
| Level 1 | Level 2 | Level 3 | Carrying | |
| fair value | fair value | fair value | amount | |
| Fair value and carrying amount of financial instruments | £m | £m | £m | £m |
Trade and other receivables excluding prepayments and contract assets | – | – | – | 327.3 |
| Trade and other payables excluding contract liabilities | ||||
and customer advances | – | – | (3.3) | (236.8) |
| Investments in equity instruments designated at initial | ||||
recognition at fair value through other comprehensive income (see note 12) | 0.7 | – | 28.6 | 29.3 |
Investment in debt instruments | – | – | 18.9 | 18.9 |
Forward exchange contract assets | – | 1.7 | – | 1.7 |
Cash and cash equivalents | – | 228.1 | – | 228.1 |
Forward exchange contract liabilities | – | (2.5) | – | (2.5) |
| 366.0 |
| Reconciliation of level 3 fair value for deferred and contingent consideration receivable/payable | 2023 | 2022 |
| on acquisitions | £m | £m |
At 1 January | (3.3) | (1.5) |
| Deferred and contingent consideration arising from current year acquisitions | ||
payable in future years | (3.0) | (2.2) |
| Deferred and contingent consideration arising from current year acquisitions | ||
receivable in future years | 0.5 | – |
| Deferred and contingent consideration paid in the current year relating to previous | ||
years’ acquisitions | 1.9 | 1.6 |
Deferred and contingent consideration transferred to liabilities held for sale | 1.3 | – |
| Costs charged to the Consolidated Income Statement: | ||
Subsequent adjustments on acquisitions and disposals | (7. 5) | (1.0) |
Foreign exchange difference | – | (0.2) |
At 31 December | (10.1) | (3.3) |
| 2023 | 2022 | |
| Reconciliation of level 3 fair value for investment in equity instruments | £m | £m |
At 1 January | 28.6 | 23.1 |
Fair value movement on level 3 investment in equity instruments | (4.2) | 4.1 |
Foreign exchange difference | (0.5) | 1.4 |
At 31 December | 23.9 | 28.6 |
| 2023 | 2022 | |
| Reconciliation of level 3 fair value for investment in debt instruments | £m | £m |
At 1 January | 18.9 | 23.0 |
Fair value movement on level 3 investment in debt instruments | 2.8 | (4.1) |
At 31 December | 21.7 | 18.9 |
| 2023 | 2022 | |
| Analysis of movements in hedging reserve, net of tax | £m | £m |
At 1 January | (3.1) | (3.5) |
Amounts removed from the Consolidated Statement of Changes in Equity and included in the Consolidated Income Statement during the year | (4.5) | 3.7 |
Amounts recognised in the Consolidated Statement of Changes in Equity during the year | 9.5 | (3.3) |
At 31 December | 1.9 | (3.1) |
| 2023 | 2022 | |
| Forward exchange contracts at 31 December | £m | £m |
Foreign currency sale amount (£m) | 175.4 | 117.2 |
| Percentage of total: | ||
US Dollar | 44% | 36% |
Chinese Yuan Renminbi | 23% | 25% |
Euro | 10% | 15% |
Japanese Yen | 14% | 15% |
Other | 9% | 9% |
2023 | 2022 | |||||||
| Derivative | Unsecured | Derivative | Unsecured | |||||
| financial | Overdrafts | loans | Total | financial | Overdrafts | loans | Total | |
| Maturity of financial liabilities | liabilities | £m | £m | £m | liabilities | £m | £m | £m |
Due within one year | 0.1 | – | – | 0.1 | 2.3 | 0.1 | – | 2.4 |
Due between one and two years | 0.1 | – | – | 0.1 | 0.2 | – | – | 0.2 |
0.2 | – | – | 0.2 | 2.5 | 0.1 | – | 2.6 |
Financial assets | Financial liabilities | |||||||
| 2023 | ||||||||
| Fixed | Floating | Non interest | Fixed | Floating | Net financial | |||
| rate | rate | bearing | Total | rate | rate | Total | assets | |
| Interest rate exposure of financial assets and liabilities by currency | £m | £m | £m | £m | £m | £m | £m | £m |
Sterling | 35.1 | 1.9 | 7.1 | 44.1 | – | – | – | 44.1 |
Euro | 2.0 | 0.6 | 19.5 | 22.1 | – | – | – | 22.1 |
US Dollar | 4.5 | 4.2 | 17.4 | 26.1 | – | – | – | 26.1 |
Other | 3.4 | 23.9 | 19.2 | 46.5 | – | – | – | 46.5 |
45.0 | 30.6 | 63.2 | 138.8 | – | – | – | 138.8 |
Financial assets | Financial liabilities | |||||||
| 2022 | ||||||||
| Fixed | Floating | Non interest | Fixed | Floating | Net financial | |||
| rate | rate | bearing | Total | rate | rate | Total | assets | |
| Interest rate exposure of financial assets and liabilities by currency | £m | £m | £m | £m | £m | £m | £m | £m |
Sterling | 90.2 | 13.7 | 8.2 | 112.1 | – | – | – | 112.1 |
Euro | 0.1 | 0.5 | 21.9 | 22.5 | – | – | – | 22.5 |
US Dollar | 1.4 | 5.1 | 19.6 | 26.1 | (0.1) | – | (0.1) | 26.0 |
Other | 0.2 | 36.2 | 31.0 | 67.4 | – | – | – | 67.4 |
91.9 | 55.5 | 80.7 | 228.1 | (0.1) | – | (0.1) | 228.0 |
2023 | 2022 | |||
| Decrease/ | Decrease/ | |||
| (increase) in | (increase) in | |||
| Decrease/ | profit before tax | Decrease/ | profit before tax | |
| (increase) in | from continuing | (increase) in | from continuing | |
| Impact on foreign exchange translational | equity | operations | equity | operations |
| exposures against Sterling | £m | £m | £m | £m |
10% weakening in the US Dollar | 128.3 | 7.9 | 130.2 | 6.9 |
10% weakening in the Euro/Danish Krone | 78.4 | 8.0 | 78.0 | 4.8 |
| 10% weakening in the Chinese Yuan | ||||
Renminbi | 4.2 | 2.0 | 5.5 | 3.6 |
| Impact of interest rate movements | ||||
1pp increase in interest rates | (0.3) | (0.3) | (0.6) | (0.6) |
2023 | 2022 | |||||
| Plant and | Plant and | |||||
| Undiscounted lease liability | Property | equipment | Total | Property | equipment | Total |
| maturity analysis under IFRS 16 | £m | £m | £m | £m | £m | £m |
Less than one year | 9.7 | 3.6 | 13.3 | 10.8 | 3.1 | 13.9 |
One to five years | 23.8 | 5.2 | 29.0 | 25.0 | 3.9 | 28.9 |
More than five years | 33.9 | – | 33.9 | 34.9 | 0.1 | 35.0 |
| Total undiscounted lease | ||||||
liabilities at 31 December | 67.4 | 8.8 | 76.2 | 70.7 | 7.1 | 77.8 |
| 2023 | 2022 | |
| £m | £m | |
Short-term benefits | 6.8 | 7. 2 |
Post-employment benefits | 0.1 | 0.1 |
Equity-settled share-based payment expense | 3.5 | 3.1 |
10.4 | 10.4 |
Name | Country of incorporation |
Malvern Panalytical Limited | England & Wales |
Servomex Group Limited | England & Wales |
Hottinger Brüel & Kjær GmbH | Germany |
Particle Measuring Systems, Inc. | USA |
Red Lion Controls, Inc. | USA |